Adherium (ASX:ADR), a leader in respiratory eHealth and remote patient monitoring, has been awarded about $880,000 by the UK National Health Service’s Small Business Research Initiative Healthcare for a pathfinder service development project.
The project is focused on providing early intervention and monitoring to high risk children with asthma, using Adherium's clinically proven Hailie® Digital Inhaler Solution.
The aim of the project is to reduce asthma attacks, with completion expected by December 2023.